View in EDS

The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44.

Saved in:
Bibliographic Details
Title: The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44.
Authors: Zhao C; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Thompson BJ; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Chen K; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Gao F; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Blouw B; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Marella M; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Zimmerman S; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Kimbler T; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Garrovillo S; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Bahn J; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Huang L; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Huang Z; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Shepard HM; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Rosengren S; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Thanos CD; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA., Maneval DC; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.
Source: Oncotarget [Oncotarget] 2019 Nov 12; Vol. 10 (61), pp. 6561-6576. Date of Electronic Publication: 2019 Nov 12 (Print Publication: 2019).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31762938
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhao+C%22">Zhao C</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Thompson+BJ%22">Thompson BJ</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Gao+F%22">Gao F</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Blouw+B%22">Blouw B</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Marella+M%22">Marella M</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Zimmerman+S%22">Zimmerman S</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Kimbler+T%22">Kimbler T</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Garrovillo+S%22">Garrovillo S</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Bahn+J%22">Bahn J</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Huang+L%22">Huang L</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Huang+Z%22">Huang Z</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Shepard+HM%22">Shepard HM</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Rosengren+S%22">Rosengren S</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Thanos+CD%22">Thanos CD</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.; Formerly of Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Maneval+DC%22">Maneval DC</searchLink>; Halozyme Therapeutics, Inc., San Diego, CA, 92121, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2019 Nov 12; Vol. 10 (61), pp. 6561-6576. <i>Date of Electronic Publication: </i>2019 Nov 12 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31762938
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18632/oncotarget.27302
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6561
    Titles:
      – TitleFull: The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhao C
      – PersonEntity:
          Name:
            NameFull: Thompson BJ
      – PersonEntity:
          Name:
            NameFull: Chen K
      – PersonEntity:
          Name:
            NameFull: Gao F
      – PersonEntity:
          Name:
            NameFull: Blouw B
      – PersonEntity:
          Name:
            NameFull: Marella M
      – PersonEntity:
          Name:
            NameFull: Zimmerman S
      – PersonEntity:
          Name:
            NameFull: Kimbler T
      – PersonEntity:
          Name:
            NameFull: Garrovillo S
      – PersonEntity:
          Name:
            NameFull: Bahn J
      – PersonEntity:
          Name:
            NameFull: Huang L
      – PersonEntity:
          Name:
            NameFull: Huang Z
      – PersonEntity:
          Name:
            NameFull: Shepard HM
      – PersonEntity:
          Name:
            NameFull: Rosengren S
      – PersonEntity:
          Name:
            NameFull: Thanos CD
      – PersonEntity:
          Name:
            NameFull: Maneval DC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 11
              Text: 2019 Nov 12
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1949-2553
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 61
          Titles:
            – TitleFull: Oncotarget
              Type: main
ResultId 1